ZifamProducts

Find Product

Categories

Zifam Sovir Plus

  • ENG
  • မြန်မာ

Composition:

Each film coated tablet contains:
Sofosbuvir …………………….. 400 mg
Ledipasvir …………………….. 90 mg
Excipients: q.s.
Colour: Lake sunset yellow FCF

Therapeutic indication:

ZIFAM SOVIR PLUS is indicated tor the treatment of chronic hepatitis C (CHC) with or without cirrhosis in adults and in adolescent aged 12 to < 18 years (weight>/= 35kg).

Adverse effects:

The most common adverse reactions (incidence greater than or equal to 10% all grades) observed with treatment with ZIFAM SOVIR PLUS were fatigue, headache and asthenia. Adverse drug reactions to ZIFAM SOVIR PLUS + ribavirin combination therapy were consistent with the known safety profile of ribavirin, without increasing the frequency or severity of the expected adverse drug reactions. No new adverse drug reactions were detected among patients with decompensated cirrhosis and/or who were post-liver transplant and who received ledipasvir/sofosbuvir with ribavirin

Facebook Comments
Related Products